Related references
Note: Only part of the references are listed.A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors
Mats Remberger et al.
CLINICAL TRANSPLANTATION (2013)
Immune Reconstitution after Double Umbilical Cord Blood Stem Cell Transplantation: Comparison with Unrelated Peripheral Blood Stem Cell Transplantation
Caron A. Jacobson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus
Malgorzata Mikulska et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Novel treatment concepts for graft-versus-host disease
Dominik Wolf et al.
BLOOD (2012)
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
Claudio G. Brunstein et al.
BLOOD (2012)
IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD
C. M. Jol-van der Zijde et al.
BONE MARROW TRANSPLANTATION (2012)
Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant
Robert Chiesa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Paediatric Reference Values for the Peripheral T cell Compartment
E. J. H. Schatorje et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantation
Mats Remberger et al.
TRANSPLANT IMMUNOLOGY (2012)
Serious Infection Risk and Immune Recovery after Double-Unit Cord Blood Transplantation Without Antithymocyte Globulin
Craig Sauter et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients
Filippo Milano et al.
BLOOD (2011)
Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation
Austen Worth et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases
A. Ruggeri et al.
TRANSPLANT INFECTIOUS DISEASE (2011)
Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases
Vanderson Rocha et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood
Claudio G. Brunstein et al.
BLOOD (2010)
How I treat adenovirus in hematopoietic stem cell transplant recipients
Caroline A. Lindemans et al.
BLOOD (2010)
Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source
P. Chevallier et al.
BONE MARROW TRANSPLANTATION (2010)
Unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients: A meta-analysis
Jing Wang et al.
LEUKEMIA RESEARCH (2010)
Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors
Margaret L. MacMillan et al.
BLOOD (2009)
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units
Michael R. Verneris et al.
BLOOD (2009)
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia
R. Willemze et al.
LEUKEMIA (2009)
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
Mary Eapen et al.
LANCET (2007)
T cell regeneration in pediatric allogeneic stem cell transplantation
H. Olkinuora et al.
BONE MARROW TRANSPLANTATION (2007)
EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning
Jonathan M. Cohen et al.
LEUKEMIA & LYMPHOMA (2007)
Immune reconstitution after unrelated cord blood transplantation
P. Szabolcs et al.
CYTOTHERAPY (2007)
Antigen-specific T-lymphocyte function after cord blood transplantation
Geoff Cohen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation
Robertson Parkman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Naive CD4+ cells from cord blood can generate competent Th effector cells
E Cantó et al.
TRANSPLANTATION (2005)
How to improve the search for an unrelated haematopoietic stem cell donor.: Faster is better than more!
MBA Heemskerk et al.
BONE MARROW TRANSPLANTATION (2005)
Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning
J Cohen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation
K Talvensarri et al.
BLOOD (2002)
Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children -: a Eurocord analysis
T Niehues et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Analysis of immune reconstitution in children undergoing cord blood transplantation
A Moretta et al.
EXPERIMENTAL HEMATOLOGY (2001)
Share Paper
